Publications
Most Food Labeling Class Actions Remain Stayed While FDA Process Runs ‘Natural’ Course
October 23, 2017
Consumer class actions over the use of the term ‘‘natural’’ on product labels should be stayed in deference to the Food and Drug Administration’s ongoing consideration of regulatory action, Sidley lawyers Amy Lally and Amanda Farfel say. The large number of comments received by the FDA on the topic reflects the complexity of the issues and the need for expert guidance from the agency the authors say.
Capabilities
Suggested News & Insights
Sidley Represents Apollo Funds in US$4.1 Billion Sale of Kelvion to SLBSeptember 1, 2026Sidley Represents Mubadala Capital in Its Acquisition of Arrive LogisticsAugust 28, 2026A Purchase-Price Adjustment Is Not the End of the Road with Indemnification on the TableAugust 24, 2026Eight Sidley Lawyers Named to Benchmark Litigation’s 2026 “Top 250 Women in Litigation” ListAugust 14, 2026Six Sidley Partners Featured in Benchmark Litigation’s 2026 “40 & Under List”August 11, 2026Sidley Shortlisted at the Benchmark Europe Awards 2026August 7, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory
